About US
Contact us
-
Lilly earnings fall despite sales increaseEli Lilly has reported a decline in it third quarter earnings despite a 9% sales increase attributed to its Cymbalta and Alimta medications. Earnings fell 5%, with net income falling to $1.24bn, as h2011/10/25
-
SFDA Commissioner Shao Mingli meets U.S. Department of Commerce Biotechnology and Life Sciences Trade Mission to ChinaOn October 14, 2011, Shao Mingli, Commissioner of the State Food and Drug Administration (SFDA), met with the U.S. Department of Commerce Biotechnology and Life Sciences Trade Mission to China led by2011/10/21
-
SFDA Deputy Commissioner Bian Zhenjia attends 2011 Sino-U.S. Pharmaceutical Industry SummitThe 2011 Sino-U.S. Pharmaceutical Industry Summit, jointly organized by the China Pharmaceutical Industry Research and Development Association (SINO-PhIRDA) and the Pharmaceutical Research and Manufac2011/10/21
-
Roche to acquire AnadysRoche has signed a definitive merger agreement to acquire Anadys Pharmaceuticals, a manufacturer of antiviral drug compunds, for a total cash consideration of approximately $230m. As per the merger a2011/10/20
-
SFDA promulgates Measures for Drug Supervision and Management in Medical Institutions (interim)In order to strengthen the drug quality supervision in medical institutions, further standardize the use of drugs of medical institutions, the State Food and Drug Administration (SFDA) recently promul2011/10/19
-
Roquette Pharma Introduces New Natural Inert Polymer and Ready to Use Coating SystemRoquette Pharma's new natural inert polymer and ready to use coating system for fast aqueous film coating saves time by up to 50% or more. The key benefits are: Natural origin Superior organolept2011/10/19
-
Roche to acquire hepatitis C specialist AnadysRoche has agreed to purchase US-based Anadys Pharmaceuticals, a specialist in hepatitis C treatments, for around $230m in cash. Roche's attraction to Anadys is focused on the company's ANA598 compoun2011/10/19
-
Bayer and Onyx restructure oncology collaborationBayer HealthCare and Onyx Pharmaceuticals have restructured their oncology partnership relating to the medication Nexavar and late-stage compound regorafenib. As per the revised agreement, Nexavar wi2011/10/18
-
Roche acquires HCV manufacturerSwiss drug company Roche has entered into a definite merger agreement to acquire Anadys Pharmaceuticals for $230 million. The company said on Monday that it will buy Anadys, a developer of oral and s2011/10/18
-
Scientists conclude pesticide contamination as a major problem in EuropeList of chemicals to be monitored should be updated immediately Pesticides are a bigger problem than had long been assumed. This is the conclusion of a study in which scientists analysed data on 5002011/10/17